np event 2254995 0E193A 1
May 29, 2024
- May 28, 2025
FcRn Inhibition for the Treatment of Generalized Myasthenia Gravis (gMG): Patient Selection, Tailoring Dosing Regimens, Updated Disease Management Paradigms
1.0

Claim your AMA PRA Category 1 Credit(s), CNE Contact Hour(s) or CPE Contact Hour(s) (CEUs) credit

Login to take this course.

This course is available for logged in users only. Please login or register to take the course.

Related Courses

np document 888746 0E193A 5
Cardiology
Obstructive Hypertrophic Cardiomyopathy: Evidence-Based, Specific Pathology-Targeted Manag...
Group 39553
Cardiometabolic
LIVE UPDATE FROM ACC25: More Support for the “Factor XI Hypothesis”
Group 39553
Cardiometabolic
MANAGEMENT OF PSVT: UPDATE FROM ACC25